These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35531909)

  • 41. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
    Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
    Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit.
    Karl J; Borgya A; Gallusser A; Huber E; Krueger K; Rollinger W; Schenk J
    Scand J Clin Lab Invest Suppl; 1999; 230():177-81. PubMed ID: 10389216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rapid and cost-effective method of producing recombinant proBNP and NT-proBNP variants in Escherichia coli for immunoassay of heart failure.
    Soleh MT; Foo JY; Bailey UM; Tan NY; Wan Y; Cooper-White J; Schulz BL; Punyadeera C
    Biotechnol Lett; 2014 Jan; 36(1):133-40. PubMed ID: 24101238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of N-terminal pro-brain natriuretic peptide levels to predict success of weaning from intra-aortic balloon pumping.
    Tokita Y; Yamamoto T; Sato N; Hosokawa Y; Munakata R; Akutsu K; Shimizu W; Tanaka K
    Am J Cardiol; 2014 Sep; 114(6):942-5. PubMed ID: 25073567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma N-terminal pro-brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy.
    Siebenhofer A; Ng LL; Plank J; Berghold A; Hödl R; Pieber TR
    Diabet Med; 2003 Jul; 20(7):535-9. PubMed ID: 12823233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
    Miller WL; Hartman KA; Burritt MF; Borgeson DD; Burnett JC; Jaffe AS
    Clin Chem; 2005 Mar; 51(3):569-77. PubMed ID: 15615816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α.
    Gruden G; Barutta F; Chaturvedi N; Schalkwijk C; Stehouwer CD; Pinach S; Manzo M; Loiacono M; Tricarico M; Mengozzi G; Witte DR; Fuller JH; Perin PC; Bruno G
    Diabetes Care; 2012 Sep; 35(9):1931-6. PubMed ID: 22699286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide.
    Ozkan HA; Bal C; Gulbas Z
    Transfus Apher Sci; 2014 Feb; 50(1):46-52. PubMed ID: 24382557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
    Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
    Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.
    Sanz MP; Borque L; Rus A; Vicente B; Ramírez Y; Lasa L
    J Clin Lab Anal; 2006; 20(6):227-32. PubMed ID: 17115420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
    Saenger AK; Rodriguez-Fraga O; Ler R; Ordonez-Llanos J; Jaffe AS; Goetze JP; Apple FS
    Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
    Chien TI; Chen HH; Kao JT
    Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation.
    Knudsen MSS; Eismark F; Goetze JP; Gustafsson F; Wolsk E
    Peptides; 2021 Jan; 135():170420. PubMed ID: 33058962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.